Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Benitec Biopharma Limited (BNTC) had Free Cash Flow per Share of $-0.40 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-9.35M |
|
-- |
|
-- |
|
$10.19M |
|
$-10.19M |
|
$0.83M |
|
$-9.35M |
|
$-9.35M |
|
$-9.35M |
|
$-9.35M |
|
$-9.35M |
|
$-9.35M |
|
$-10.19M |
|
$-10.18M |
|
38.60M |
|
38.60M |
|
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
$104.01M |
|
$0.14M |
|
$1.20M |
|
$105.21M |
|
$7.03M |
|
$0.61M |
|
$0.61M |
|
$7.64M |
|
$97.57M |
|
$97.57M |
|
$97.57M |
|
25.55M |
|
| Cash Flow Statement Financials | |
$-15.38M |
|
$-0.02M |
|
$67.94M |
|
$50.93M |
|
$103.65M |
|
$52.72M |
|
$3.98M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.80 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.59% |
|
-9.59% |
|
-8.89% |
|
-9.53% |
|
$3.82 |
|
|
Free Cash Flow per Share |
$-0.40 |
$-0.40 |
|